Panthera Biopartners raises £10 million in round led by BGF and Gresham House Ventures
Panthera Biosciences (Panthera) has secured £10 million of investment from BGF and Gresham House Ventures, the latter investing on behalf of the Baronsmead VCTs. This investment will allow Panthera to further grow its network of dedicated clinical trial sites across the UK and Western Europe. Since launching in late 2019,